Y0001975

Zolmitriptan

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): (4S)-4-((3-(2-(Dimethylamino)-ethyl)-1H-indol-5-yl)-methyl)-2-oxazolidinon, (S)-4-((3-(2-(Dimethylamino)-ethyl)-indol-5-yl)-methyl)-2-oxazolidinon
• Empirische Formel (Hill-System): C₁₆H₂₁N₃O₂
• CAS-Nummer: 139264-17-8
• Molekulargewicht: 287.36
• MDL-Nummer: MFCD00871503
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: zolmitriptan
• Hersteller/Markenname: EDQM
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12
• InChI: 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
• InChIKey: ULSDMUVEXKOYBU-ZDUSSCGKSA-N
• Angaben zum Gen: human ... HTR1B(3351) , HTR1D(3352)

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Zolmitriptan EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem./physiol. Wirkung

Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of migraine attacks with or without aura and cluster headaches.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable